ArticleJournal for immunotherapy of cancer2019

Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients.

Adam E Snook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.